Overview

Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury

Status:
Recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the days until reaching clinical stability after starting randomization in hospitalized patients with elevated inflammatory parameters and severe COVID-19 lung injury.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Universitari de Bellvitge
Collaborator:
Institut d'Investigació Biomèdica de Bellvitge
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Tacrolimus